NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Update

Volatility Index Surges 121% in 2026

As of March 4, 2026, the India VIX (volatility index) has surged 121% in the calendar year, while the market benchmark Nifty 50 has declined more than 6% for the same period. The sharp selling has been driven by various factors, including the US-Iran war, crude oil price rise, foreign institutional investor (FII) selloff, and rupee's weakness.

Consensus Estimates Forecast Earnings Growth

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Despite the short-term challenges, consensus estimates forecast earnings growth accelerating to 16-27% in FY27, driven by nominal GDP expansion (7-7.4%), consumption revival, capital expenditure momentum, and stable financials/infra sectors. Vinit Bolinjkar, head of research at Ventura, believes that macro stability, favorable monsoons, and policy support like GST tweaks will bolster mid-teens earnings per share (EPS), shifting from valuation expansion to delivery-led upside amid consolidation.

Value Stocks Come into Focus

The recent market volatility and fears of near-term turmoil have brought value stocks back into focus. Bolinjkar underscores that the overall scenario favors shifting to value stocks from growth. Sector rotation shows capital moving to undervalued cyclicals like banks, infra, energy, and pharma amid lower interest rates and earnings normalization.

5 Value Stocks to Buy for the Long Term

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Bolinjkar recommends buying the following five value stocks for the long term:

  1. Larsen & Toubro (L&T)
    • Previous close: ₹3,882.60
    • Target price: ₹4,448
    • L&T is India's largest and most diversified infrastructure and engineering conglomerate, serving as a proxy for the nation's growth.
  2. NBCC (India)
    • Previous close: ₹85.63
    • Target price: ₹167 (24-month horizon)
    • NBCC operates a low-risk, asset-light business model and holds a near-monopoly in India's lucrative GPRA redevelopment ecosystem.
  3. Jubilant Pharmova
    • Previous close: ₹834.30
    • Target price: ₹1,557
    • Jubilant Pharmova holds a dominant position in specialized pharma niches, including the second-largest US radio pharmacy network and allergy immunotherapy market.
  4. V-Mart Retail
    • Previous close: ₹537.80
    • Target price: ₹1,069
    • V-Mart is a leading value fashion retailer strategically targeting the aspirational, underserved populations in India's tier 2, 3, and 4 cities.
  5. Other Value Stocks (not specified in the original article)

These value stocks offer stability via dividends, cash flows, and broad EPS support in a 6.5-7.4% GDP backdrop. Macro tailwinds, liquidity, and domestic demand reward resilient, beaten-down plays over narrative-driven growth, especially with FII flows pivoting.

Investor Takeaway

Investors should consider long-term value stocks like L&T and NBCC for potential growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.